All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
BNR / Burning Rock Biotech Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
KALV / KalVista Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
SELB / Selecta Biosciences Inc
|
|
|
|
|
|
|
|
CDXS / Codexis, Inc.
|
|
|
|
|
|
|
|
WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
GLTO / Galecto, Inc.
|
|
|
|
|
|
|
|
EQ / Equillium, Inc.
|
|
|
|
|
|
|
|
HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
GMTX / Gemini Therapeutics Inc
|
|
|
|
|
|
|
|
UNH / UnitedHealth Group Incorporated
|
|
|
|
|
|
|
|
110122157 / Bristol Meyers Squibb CVR Exp. 12/31/2020
|
|
|
|
|
|
|
|
NSTG / NanoString Technologies, Inc.
|
|
|
|
|
|
|
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
FLDM / Standard BioTools Inc
|
|
|
|
|
|
|
|
FBRX / Forte Biosciences, Inc.
|
|
|
|
|
|
|
|
TPTX / Turning Point Therapeutics Inc
|
|
|
|
|
|
|
|
FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
VTRS / Viatris Inc.
|
|
|
|
|
|
|
|
GRAY / Graybug Vision Inc
|
|
|
|
|
|
|
|
TXG / 10x Genomics, Inc.
|
|
|
|
|
|
|
|
MEIP / MEI Pharma, Inc.
|
|
|
|
|
|
|
|
STRO / Sutro Biopharma, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
NCNA / NuCana plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ILMN / Illumina, Inc.
|
|
|
|
|
|
|
|
BDSX / Biodesix, Inc.
|
|
|
|
|
|
|
|
PODD / Insulet Corporation
|
|
|
|
|
|
|
|
GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
RCUS / Arcus Biosciences, Inc.
|
|
|
|
|
|
|
|
BLSA / BCLS Acquisition Corp - Class A
|
|
|
|
|
|
|
|
AVDL / Avadel Pharmaceuticals plc
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|